This retrospective study aimed to develop and validate an Ultrasound (US)‐based nomogram to predict short disease‐free survival (short‐DFS, less than 120 months DFS) in breast cancer (BC). Click to show full abstract
This retrospective study aimed to develop and validate an Ultrasound (US)‐based nomogram to predict short disease‐free survival (short‐DFS, less than 120 months DFS) in breast cancer (BC).
               
Click one of the above tabs to view related content.